Market Research Report
Cytomegalovirus (CMV) Infections - Epidemiology Forecast-2028
|Published by||DelveInsight Business Research LLP||Product code||402149|
|Published||Content info||109 Pages
Delivery time: 1-2 business days
|Cytomegalovirus (CMV) Infections - Epidemiology Forecast-2028|
|Published: September 1, 2019||Content info: 109 Pages||
DelveInsight's 'Cytomegalovirus (CMV) Infections - Epidemiology Forecast-2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology trends of Cytomegalovirus (CMV) Infections in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
There are certain groups at high risk for serious complications from CMV infection which includes: Pregnant Women, Transplant Patients with compromised immune systems, Patients with HIV, and Very low birth weight and premature infants.
Study Period: 2017-2028
Cytomegalovirus (CMV) is a commonly acquired infection and a member of the Herpesviridae family. Cytomegalovirus infection (CMV) is a viral infection that rarely causes obvious illness. There are three main types of CMV infections: acquired, recurring, or congenital. When the infection develops for the first time it is called acquired CMV. Recurrent CMV infection is defined as a new CMV infection in a patient with previous evidence of CMV infection in whom the virus has not been detected for at least 4 weeks during active surveillance. If a pregnant woman has an active CMV infection, the virus can be passed to the unborn baby and when it affects a baby in the womb, it's known as congenital CMV.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Seroprevalence of CMV in 7MM, Total Diagnosed Cases of Cytomegalovirus (CMV) Infection in 7MM, Number of Infants born with Congenital CMV in 7MM, CMV Patients among Hematopoietic Stem Cell Transplants (HSCT) in 7MM, Number of CMV Patients among Solid Organ Transplants (SOT) in 7MM, Number of Refractory CMV Patients after HSCT/SOT in 7MM and CMV Retinitis among HIV Patients in 7MM) scenario of Cytomegalovirus (CMV) Infections in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2028.
According to DelveInsight, the total diagnosed cases of CMV were found out to be approximately 110,540 in the 7MM. The number of CMV cases in the 7MM is expected to increase during the study period of 2017-2028.
The estimates suggest higher diagnosed cases of CMV in the United States with around 70,207 cases in 2017. Among the European countries, France had the highest diagnosed cases of CMV with approximately 8,920 cases, followed by the United Kingdom which had diagnosed population of around 7,420 in 2017. On the other hand, Italy had the lowest diagnosed incident population of approximately 3,850 in 2017.
In the US, the total number of HSCT (allogeneic HSCT) patients were found out to be approximately 9,470 in 2017. It has been observed that approximately 46.94% of total HSCT (Allogeneic) patients are diagnosed with CMV. According to DelveInsight estimates, out of the total HSCT (allogeneic) patients, the number of CMV patients were found out to be around 4,407 in 2017.